Page 8 - Randomized Trial News Today

UVA Health has joined a nationwide study evaluating two repurposed medications in the search for effective, safe treatments for mild to moderate COVID-19. Repurposed medications are already approved by the U.S. Food and Drug Administration for the tr

People from throughout Virginia and across the U.S. can get more information on how to participate in COVID ivermectin trial activ6study.org or 833.385.1880.

UVA Health has joined a nationwide study evaluating two repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19.

People from throughout Virginia and across the U.S. can get more information on how to participate in COVID ivermectin trial activ6study.org or 833.385.1880.

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

Study focuses on medicines that are already on the market for other illnesses.

Large randomized study of two approaches to support rural primary care providers in caring for people with PTSD or bipolar disorder shows both work

Essentia Health serves as a clinical research site supporting ACTIV-6 by referring eligible study participants. It will enroll and monitor patients’ progress throughout the study’s 90-day follow-up period and will assist them with any questions or concerns that arise.